Table 2 Base line clinical characteristics of patients
Variables | Categories | Survival status | Total (%) | |
|---|---|---|---|---|
Censored (%) | Event (%) | |||
Functional status | Working | 188 (68.36) | 87 (31.64) | 275 (68.2) |
Ambulatory | 23 (22.77) | 78 (77.2) | 101 (25.1) | |
Bedridden | 14 (51.85) | 13 (48.15) | 27 (6.7) | |
Adherence | Poor | 7 (43.75) | 9 (56.25) | 16 (4.0) |
Fair | 43 (49.43) | 44 (50.57) | 87 (21.6) | |
Good | 175 (58.33) | 125 (41.67) | 300 (74.4) | |
WHO clinical stage | Stage-I | 114 (50.89) | 110 (49.11) | 224 (55.6) |
Stage-II | 53 (68.83) | 24 (31.17) | 77 (19.1) | |
Stage-III | 47 (63.51) | 27 (36.49) | 74 (18.4) | |
Stage-IV | 11 (39.29) | 17 (60.71) | 28 (6.9) | |
TB screen | No | 216 (62.25) | 131 (37.75) | 347 (86.1) |
Yes | 9 (16.07) | 47 (83.93) | 56 (13.9) | |
OIs | No | 198 (61.68) | 123 (38.32) | 321 (79.7) |
Yes | 27 (32.93) | 55 (67.07) | 82 (20.3) | |
OCC | No | 203 (64.65) | 111 (35.35) | 314 (77.9) |
Yes | 22 (24.72) | 67 (75.28) | 89 (22.1) | |
Continuous variables | Minimum | Maximum | Mean | Standard error |
|---|---|---|---|---|
Hematocrit in % | 20.80 | 54.30 | 37.66 | 4.50 |
White blood cell in 103/\(\mu l\) | 1.60 | 13.00 | 6.01 | 1.88 |
Red Blood Cell in 106/\(\mu l\) | 2.00 | 11.00 | 4.17 | 1.35 |
Platelet in 103/\(\mu l\) | 23 | 641 | 286.93 | 95.25 |
Lymphocyte in % | 15.20 | 69.10 | 42.69 | 11.32 |
Monocyte in % | 2.0 | 13.4 | 7.33 | 3.13 |